senktide has been researched along with argipressin, beta-mercapto beta,beta-cyclopentamethylenepropionic acid(1)-o-methyl-tyr(2)-val(4)- in 1 studies
Studies (senktide) | Trials (senktide) | Recent Studies (post-2010) (senktide) | Studies (argipressin, beta-mercapto beta,beta-cyclopentamethylenepropionic acid(1)-o-methyl-tyr(2)-val(4)-) | Trials (argipressin, beta-mercapto beta,beta-cyclopentamethylenepropionic acid(1)-o-methyl-tyr(2)-val(4)-) | Recent Studies (post-2010) (argipressin, beta-mercapto beta,beta-cyclopentamethylenepropionic acid(1)-o-methyl-tyr(2)-val(4)-) |
---|---|---|---|---|---|
292 | 1 | 50 | 14 | 0 | 0 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kamiya, H; Nakayama, Y; Saito, R; Takano, Y | 1 |
1 other study(ies) available for senktide and argipressin, beta-mercapto beta,beta-cyclopentamethylenepropionic acid(1)-o-methyl-tyr(2)-val(4)-
Article | Year |
---|---|
Central pressor actions of tachykinin NK-3 receptor in the paraventricular nucleus of the rat hypothalamus.
Topics: Animals; Arginine Vasopressin; Blood Pressure; Injections; Male; Paraventricular Hypothalamic Nucleus; Peptide Fragments; Pressoreceptors; Rats; Rats, Wistar; Receptors, Neurotransmitter; Receptors, Tachykinin; Substance P; Vasopressins | 1992 |